Literature DB >> 17972949

Rituximab in CD20 positive multiple myeloma.

J M Bergua, C Cabrera, E G Arteta, J Prieto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17972949     DOI： 10.1038/sj.leu.2405010

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Diagnostic and treatment hurdles in plasma cell myeloma with t(11;14) translocation: A case report.

Authors:  Shun Yin Kong; Wing Kit Lam; Ka Shu Li; Ka Pik Yeung; Chung Yin Ha; Ho Kei Lai; Hay Nun Chan; Yiu Ming Yeung; Sze Fai Yip
Journal:  Mol Clin Oncol       Date:  2018-04-24

Review 2.  Multiple myeloma in the marrow: pathogenesis and treatments.

Authors:  Heather Fairfield; Carolyne Falank; Lindsey Avery; Michaela R Reagan
Journal:  Ann N Y Acad Sci       Date:  2016-01       Impact factor: 5.691

3.  Rituximab in the treatment of non-Hodgkin's lymphoma.

Authors:  Beate Hauptrock; Georg Hess
Journal:  Biologics       Date:  2008-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.